Cora Sternberg | Meta analysis | Outstanding Scientist Award

Dr. Cora Sternberg | Meta analysis | Outstanding Scientist Award

Weill Cornell Medicine | United States

Author Profiles

Scopus

Orcid ID

Google Scholar

Early Academic Pursuits

Dr. Cora Sternberg’s academic journey reflects her commitment to excellence from the outset. She completed her medical training with distinction and pursued advanced fellowships, including a Research Fellowship in Immunology at the National Institutes of Health (1976–1977). Her early academic roles as Teaching Assistant at Stanford and Mount Sinai, followed by Clinical Instructor at Cornell University, laid the foundation for her lifelong dedication to education and clinical research. Her Phi Beta Kappa distinction from the University of Pennsylvania marked the start of a career dedicated to innovation and leadership in oncology.

Professional Endeavors

Over four decades, Dr. Sternberg has held prestigious academic and clinical leadership roles. She was Chief of Medical Oncology at San Camillo-Forlanini Hospital in Rome and served as Professor at La Sapienza University, shaping Italy’s oncology community. Since 2018, she has been Professor of Medicine and Clinical Director of the Englander Institute for Precision Medicine at Weill Cornell Medicine and New York-Presbyterian. She has also served as a global faculty member at Temple University, Tufts University, and European institutions.

Contributions and Research Focus

Dr. Sternberg has pioneered groundbreaking research in prostate cancer, bladder cancer, and renal cell carcinoma. She was instrumental in developing practice-changing therapies such as abiraterone, enzalutamide, and darolutamide, significantly improving survival outcomes for prostate cancer patients. Her work in urothelial cancer led to the establishment of M-VAC chemotherapy and global adoption of immunotherapy protocols. She also contributed to the development of pazopanib and other targeted therapies in renal cell carcinoma. Recently, she has expanded her research focus to artificial intelligence in oncology, spearheading initiatives to integrate AI into therapeutic decision-making.

Impact and Influence

With over 546 publications, six textbooks, and more than 45,200 citations, Dr. Sternberg ranks among the World’s Top 2% Scientists (Stanford University) and the top 5% in the Doximity community for citations. She has delivered more than 835 lectures worldwide, influencing clinical practice, policy, and guidelines in oncology. Her leadership roles in international organizations such as ASCO, ESMO, ECCO, and EORTC demonstrate her far-reaching influence.

Academic Citations

Dr. Sternberg’s research impact is widely recognized. Her publications in high-impact journals such as New England Journal of Medicine, Lancet Oncology, and Journal of Clinical Oncology have shaped global treatment standards. Her works are consistently cited in clinical guidelines, trial protocols, and oncology education, affirming her stature as a thought leader in medical oncology.

Legacy and Future Contributions

Dr. Sternberg’s legacy lies not only in transformative research but also in mentorship. She has nurtured generations of oncologists, fostering innovation and translational research. Currently, she co-leads the Career Development Program in the Bladder SPORE initiative, ensuring the pipeline of future oncology leaders. Her pioneering role in AI in oncology positions her to continue shaping the future of precision medicine, bridging clinical care with technological innovation.

Conclusion

Dr. Cora Sternberg exemplifies the qualities of an Outstanding Scientist—visionary leadership, transformative research, global influence, and unwavering dedication to advancing oncology. Her lifelong contributions to clinical practice, groundbreaking research, academic mentorship, and adoption of emerging technologies ensure her lasting impact on the medical community and future generations of scientists.

Notable Publications

"Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100

  • Author: homas Powles; Srikala S. Sridhar; Joaquim Bellmunt; Cora N. Sternberg; Petros Grivas; Ewan Hunter; Matthew Salter; Ryan Powell; Ann Dring; Jayne Green et al.
  • Journal: Cancers
  • Year: 2025

"The Use of Artificial Intelligence for Cancer Therapeutic Decision-Making

  • Author: Olivier Elemento; Sean Khozin; Cora N. Sternberg
  • Journal: NEJM AI
  • Year: 2025

"Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100

  • Author: Thomas Powles; Srikala S. Sridhar; Joaquim Bellmunt; Cora N. Sternberg; Petros Grivas; Ewan Hunter; Matthew Salter; Ryan Powell; Ann Dring; Jayne Green et al.
  • Journal: Preprint
  • Year: 2025

"Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591

  • Author: Scott T. Tagawa; Charlene Thomas; A. Oliver Sartor; Michael Sun; Judith Stangl-Kremser; Mahelia Bissassar; Shankar Vallabhajosula; Sandra Huicochea Castellanos; Jones T. Nauseef; Cora N. Sternberg et al.
  • Journal: Journal of Clinical Oncology
  • Year: 2024

"Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial

  • Author: Maha Hussain; Bertrand Tombal; Fred Saad; Karim Fizazi; Cora N. Sternberg; E. David Crawford; Neal Shore; Evgeny Kopyltsov; Arash Rezazadeh Kalebasty; Martin Bögemann et al.
  • Journal: Journal of Clinical Oncology
  • Year: 2023

 

 

Eddie Wampande | Biological Networks | Best Researcher Award

Dr. Eddie M. Wampande | Biological Networks | Best Researcher Award

Makerere University | Uganda

Author Profile

Scopus

Google Scholar

DR. EDDIE M. WAMPANDE: A VISIONARY IN INFECTIOUS DISEASE EPIDEMIOLOGY AND VETERINARY SCIENCE

EARLY ACADEMIC PURSUITS

Dr. Eddie M. Wampande began his academic journey with a scholarship awarded by the Government of Uganda to pursue a Bachelor’s Degree in Veterinary Medicine (BVM) at Makerere University from 1993 to 1998. Driven by a strong passion for infectious diseases and parasitology, he advanced to complete a Master’s degree in Molecular Biology (Parasitology) at the same university with a WHO/TDR scholarship. His academic accomplishments culminated in a Ph.D. in Molecular Epidemiology of Infectious Diseases, with a focus on the phenotypes and microevolution of Mycobacterium tuberculosis, supported by the Tuberculosis Research Unit (TBRU), Case Western Reserve University, Cleveland.

PROFESSIONAL ENDEAVORS

Dr. Wampande’s professional journey has been deeply intertwined with Makerere University. He began as a Research Assistant (2000–2002) in the Molecular Biology Laboratory and gradually progressed to Research Associate (2002–2005) and later Senior Lecturer (2005 to date). In 2012, he joined the University of Basel’s Swiss Tropical Institute and Public Health as a Research Fellow, and since 2014, he has been serving as the Director of the Central Diagnostic Laboratory. His commitment to capacity building is evident in his leadership of diagnostic and research programs, reflecting strong administrative and technical expertise.

CONTRIBUTIONS AND RESEARCH FOCUS ON BIOLOGICAL NETWORKS

Dr. Wampande's primary research focus is on the molecular epidemiology of infectious pathogens of both economic and public health significance, such as Mycobacterium tuberculosis, African Swine Fever Virus, Trypanosoma brucei, and antimicrobial-resistant pathogens. He has supervised 15 MSc students to completion, covering diverse research areas including tuberculosis genotyping, HIV diagnosis, zoonotic transmission, and antibiotic resistance. His Ph.D. mentorship includes completed theses and ongoing research projects related to TB-HIV co-infections and antimicrobial resistance dynamics in poultry farms. He has also served as external examiner for Ph.D. theses from other countries, evidencing his continental influence.

IMPACT AND INFLUENCE

Dr. Wampande has been instrumental in multiple resource mobilization efforts, securing national and international grants totaling over USD 1.3 million, supporting projects ranging from vector-borne diseases to molecular diagnostics and zoonotic infections. He led the “Stamp Out Sleeping Sickness” initiative in Eastern Uganda (2010–2015) and coordinated large-scale field surveys such as the serological bovine tuberculosis survey in Karamoja (2022) and control programs targeting tick and bacterial resistance (2015–2019). His work has directly impacted national policy on disease surveillance, diagnostics, and animal-human health interface management.

ACADEMIC CITES

His scholarly work and technical reviews have earned him appointments such as Reviewer for the International Journal of Tuberculosis and Lung Diseases (2015–2017) and BMC Infectious Diseases (2017–2020). He is a member of several key scientific bodies, including the Genome Analysis Working Group and Microbiome Working Group under H3Africa, a continent-wide initiative promoting genomic research. His contributions to genome bioinformatics were further recognized by a three-month fellowship at Baylor College of Medicine, USA, funded by the MRC/UVRI Infection and Immunity Program.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Wampande’s legacy lies in his consistent dedication to training the next generation of African scientists, advancing research infrastructure, and deepening our understanding of infectious disease epidemiology. His participation in global initiatives like the THRiVE Program (Welcome Trust, UK) and Cambridge Africa’s Alborado Research Scheme underlines his commitment to collaborative science. Looking ahead, his ongoing Ph.D. supervision, continuous research in African Swine Fever epidemiology, and further exploration of zoonotic diseases place him in a pivotal role in shaping Africa's public health research landscape.

OTHER NOTABLE TOPICS

HONORS AND FELLOWSHIPS
Dr. Wampande has received numerous accolades, including the Makerere University Research Award for Excellence, Welcome Trust Postdoctoral Fellowship, and Gates Foundation Travel Grant.

COMMUNITY ENGAGEMENT
He remains an advocate for community-inclusive scientific approaches, using participatory methods to combat diseases and ensure sustainable practices in animal husbandry, agriculture, and diagnostics across Uganda.

RESOURCE MOBILIZATION EXPERTISE
He has led and co-led research projects funded by major organizations such as the United States Department of Agriculture, Defence Threat Reduction Agency, and the WHO/TDR, contributing to cross-sectoral innovation and knowledge application in both academic and governmental contexts.

NOTABLE PUBLICATIONS

"A description of the clinical signs and lesions of African swine fever, and its differential diagnoses in pigs slaughtered at selected abattoirs in central Uganda

  • Author: JE Ekakoro, A Nassali, C Hauser, K Ochoa, D Ndoboli, R Okwasiimire
  • Journal: Frontiers in Veterinary Science
  • Year: 2025

"Detection and molecular characterisation of fowl adenovirus associated with inclusion body hepatitis and hydropericardium syndrome in Uganda

  • Author: W Eneku, R Okwasiimire, F Mutebi, M Kisekka, S Kakooza, M Afayoa
  • Journal: Tropical Animal Health and Production
  • Year: 2025

"Patterns of compensatory mutations in rpoA/B/C genes of multidrug resistant M. tuberculosis in Uganda

  • Author: DP Kateete, S Namakula, E Kigozi, FA Katabazi, GW Kasule, K Musisi
  • Journal: bioRxiv
  • Year: 2025

"Hepatoprotective effect of methanol fruit extract of Punica granatum L in highly active antiretroviral therapy-induced toxicity in Wistar rats

  • Author: E Kwizera, EM Wampande, CD Kato, P Mujinya, A Wandera, F Bwambale
  • Journal: Drug and Chemical Toxicology
  • Year: 2024

"Polymorphisms in immune genes and their association with tuberculosis susceptibility: An analysis of the African population

  • Author: W Wodelo, EM Wampande, A Andama, DP Kateete, K Ssekatawa
  • Journal: The Application of Clinical Genetics
  • Year: 2024